Molecular mechanism of human herpesvirus 6 latent infection
人类疱疹病毒6型潜伏感染的分子机制
基本信息
- 批准号:11670296
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have studied the latent and the productive infection of HHV-6 in the peripheral blood macrophages. As for the study on HHV-6 latency, four kinds of latency-associated transcripts of human herpesvirus 6 were identified, which were detected only in latently infected cells. Although they were encoded in the same direction as the immediate early (IE) 1/2 genes and shared their protein-coding region with IE1/2, their transcription start sites and exon(s) were latency-associated. Our findings revealed that the structures, the encoded proteins, and the expression of the HHV-6 latency-associated transcripts were similar to those of HCMV latency-specific transcripts. The H6LTs and the HCMV latency-specific transcripts may have some common function during latency. The conserved features of the HHV-6 and HCMV latent transcripts that we observed in this study may assist us in understanding β-herpesvirus latency further. As for the study on the acute infection, we investigated the tropism of HHV-6 in peripheral blood mononuclear cells (PBMCs) during acute infection. We detected 637 ± 273 copies of viral DNA in 10^4 MO/Mφ. In contrast, in 10^4CD4^+T cells, which have been reported to be viral carriers during the acute infection of HHV-6, we found only 115 ± 42 copies of viral DNA. Consistent with these data, virus was isolated from MO/Mφ an order of magnitude more frequently than from CD4^+ T cells. Viral mRNA U79/80, which indicates viral replication, was detectable in the MO/Mφ. In addition, the mRNAs that encode viral chemokine receptors U12 and U51, which may modify the function of MO/Mφ, were expressed in the cells. Therefore, productively infected MO/Mφ may be the dominant cell population that is responsible for HHV-6 viremia during acute HHV-6 infection. The strong interaction of HHV-6 with MO/Mφ may be partly responsible for the pathogenesis of this virus.
我们研究了HHV-6在外周血巨噬细胞中的潜伏性和生产性感染。在HHV-6潜伏期的研究中,鉴定了4种人类疱疹病毒6型潜伏相关转录物,仅在潜伏感染的细胞中检测到。虽然它们与立即早期(IE)1/2基因编码方向相同,并与IE 1/2共享其蛋白编码区,但它们的转录起始位点和外显子与潜伏期相关。我们的研究结果表明,HHV-6潜伏相关转录本的结构,编码的蛋白质和表达与HCMV潜伏特异性转录本相似。H6LTs和HCMV潜伏期特异性转录本在潜伏期可能有一些共同的功能。我们在本研究中观察到的HHV-6和HCMV潜伏转录本的保守特征可能有助于我们进一步了解β-疱疹病毒的潜伏期。在急性感染的研究方面,我们研究了HHV-6在急性感染时外周血单个核细胞(PBMCs)中的嗜性。我们在10^4 MO/M φ中检测到637 ± 273个病毒DNA拷贝。相比之下,在10^4CD4 ^+ T细胞中,我们只发现了115 ± 42个病毒DNA拷贝。与这些数据一致,从MO/M φ中分离出病毒的频率比从CD4 ^+ T细胞中高一个数量级。在MO/M φ中可检测到病毒mRNA U79/80,其指示病毒复制。此外,在细胞中表达了编码病毒趋化因子受体U12和U51的mRNA,它们可能改变MO/M φ的功能。因此,在急性HHV-6感染期间,生产性感染的MO/M φ可能是导致HHV-6病毒血症的主要细胞群。HHV-6与MO/M φ的强相互作用可能是HHV-6致病的部分原因。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tanaka-Taya K et al.: "Reactivation of human herpesvirus 6 by infection of human herpesvirus 7."Journal of Medical Virology. 60・3. 284-289 (2000)
Tanaka-Taya K 等人:“人类疱疹病毒 7 的感染重新激活”。医学病毒学杂志 60・3 284-289(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Taniguchi et al.: "Structure of transcripts and proteins encoded by U79-80 of human herpesvirus 6 and its subcellular localization in infected cells"Virology. 271. 307-320 (2000)
T.Taniguchi 等人:“人类疱疹病毒 6 型 U79-80 编码的转录物和蛋白质的结构及其在感染细胞中的亚细胞定位”病毒学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Kondo, K. Shimada, J. Sashihara, K. et al.: "Identification of human Herpesvirus 6 latency- associated transcripts"J. Virol.. 76 (8)(in press). (2002)
K. Kondo、K. Shimada、J. Sashihara、K. 等人:“人类疱疹病毒 6 潜伏相关转录物的鉴定”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Kondo, T. Kondo, K. Shimada et al.: "Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection"J. Med. Virol.. (in press). (2002)
K. Kondo、T. Kondo、K. Shimada 等:“急性感染期间人疱疹病毒 6 型与外周血单核细胞/巨噬细胞之间的强相互作用”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Tanaka-Taya, K. Kondo, K. Yamanishi et al.: "Reactivation of human herpesvirus 6 by infection of human herpesvirus 7"J. Med. Virol.. 60 (3). 284-289 (2000)
K. Tanaka-Taya、K. Kondo、K. Yamanishi 等人:“通过感染人类疱疹病毒 7 来重新激活人类疱疹病毒 6”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KONDO Kazuhiro其他文献
KONDO Kazuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KONDO Kazuhiro', 18)}}的其他基金
Development of Catalytic Synthetic Reactions with High Clark Number Elements (Without A small Amounts of Rare Metals)
高克拉克数元素(不含少量稀有金属)催化合成反应的进展
- 批准号:
22590008 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Estimation of Speech Intelligibility using Automatic Speech Recognition
使用自动语音识别估计语音清晰度
- 批准号:
20500151 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Fatigue and be-ta herpesvirus reactivation
疲劳和 β 疱疹病毒再激活
- 批准号:
19590483 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Visualization and analysis of human herpesvirus 6 and 7 using their recombinant viruses
使用重组病毒对人类疱疹病毒 6 型和 7 型进行可视化和分析
- 批准号:
17590422 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of human herpesvirus 6 latent infection in the brain.
人类疱疹病毒6型大脑潜伏感染分析。
- 批准号:
14570263 - 财政年份:2002
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene analysis of Δ^4-3-oxosteroid 5β-reductase in neonatal hepatitis patients with predominant urinary Δ^4-3-oxo bile acids
尿Δ^4-3-含氧胆汁酸为主的新生儿肝炎患者Δ^4-3-氧代类固醇5β-还原酶基因分析
- 批准号:
11671257 - 财政年份:1999
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Monitoring method of human cytomegalovirus latent infection and viral reactivation
人巨细胞病毒潜伏感染和病毒再激活的监测方法
- 批准号:
09557028 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of human herpesvirus 6 latent infector
人疱疹病毒6型潜伏感染者的分子机制
- 批准号:
09670316 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
- 批准号:32000546
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus
项目 4 - 控制 Epstein-Barr 病毒中的潜伏至裂解转换
- 批准号:
10910338 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Divergent roles of nonsense-mediated RNA decay in oncovirus latency and reactivation
无义介导的RNA衰变在肿瘤病毒潜伏和重新激活中的不同作用
- 批准号:
10880993 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Defining HIV Env protein expression in latently infected cells
定义潜伏感染细胞中的 HIV 包膜蛋白表达
- 批准号:
10762524 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Anti-HIV and anti-reactivation activities of pyrrolopyridine-based ALLINIs
基于吡咯并吡啶的 ALLINI 的抗 HIV 和抗再激活活性
- 批准号:
10762564 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
The intersection of diet, cell metabolic state, and SIV reservoir transcription
饮食、细胞代谢状态和 SIV 储存库转录的交叉点
- 批准号:
10618546 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Determining the impact of ultra-small SIV reservoirs on sustained ART-free remission
确定超小型 SIV 储库对持续无 ART 缓解的影响
- 批准号:
10792978 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Single Cell Analysis of Epigenetic Mechanisms that Regulate HIV-1 CNS Latency and Neuropathogenesis
调节 HIV-1 CNS 潜伏期和神经发病机制的表观遗传机制的单细胞分析
- 批准号:
10748578 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Antiviral and immunomodulatory effects of interferon lambda in the skin
干扰素 lambda 在皮肤中的抗病毒和免疫调节作用
- 批准号:
10637499 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infection
甲基苯丙胺使用、病毒库动态与治疗艾滋病毒感染的临床进展之间的关系
- 批准号:
10683495 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别: